Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | PPARG | P37231 | 2/20 | 0.46 |
| ▸ | PPARA | Q07869 | 2/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
| ▸ | MMP12 | P39900 | 3/20 | 0.45 |
| ▸ | MMP13 | P45452 | 3/20 | 0.45 |
| ▸ | MMP2 | P08253 | 1/20 | 0.45 |
| ▸ | MMP9 | P14780 | 1/20 | 0.45 |
| ▸ | MMP14 | P50281 | 1/20 | 0.45 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.44 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.44 |
| ▸ | CPA1 | P15085 | 2/20 | 0.43 |
| ▸ | CPB1 | P15086 | 1/20 | 0.43 |
| ▸ | CPA3 | P15088 | 1/20 | 0.43 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.43 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6803856 | 1.00 | KMT2A (0.49) | KMT2AMEN1PPARGPPARAFFAR1 | |
| SCHEMBL11826750 | 0.95 | MMP12 (0.53) | KMT2AMEN1PPARGPPARAFFAR1 | |
| SCHEMBL18031709 | 0.85 | ACACB (0.44) | KMT2AMEN1PPARGPPARAFFAR1 | |
| SCHEMBL6807540 | 0.83 | EPHX1 (0.43) | KMT2AMEN1PPARGPPARATRPA1 | |
| SCHEMBL6138407 | 0.82 | TRPA1 (0.65) | TRPA1MMP12MMP13MMP2MMP9 | |
| SCHEMBL10535065 | 0.82 | TRPA1 (0.65) | TRPA1MMP12MMP13MMP2MMP9 | |
| SCHEMBL1861755 | 0.82 | TRPA1 (0.65) | TRPA1MMP12MMP13MMP2MMP9 | |
| SCHEMBL16452830 | 0.81 | FFAR1 (0.51) | KMT2APPARGPPARAFFAR1CPA3 | |
| SCHEMBL1139059 | 0.81 | MMP12 (0.68) | FFAR1MMP12MMP13MMP2MMP9 | |
| SCHEMBL11829029 | 0.81 | PTGS1 (0.47) | KMT2AMEN1FFAR1TRPA1MMP12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10894121-B2 | Small molecule dye for molecular imaging and photothermal therapy | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2021-01-19 | — | — | US | disclosed |
| US-20190192761-A1 | SMALL MOLECULE DYE FOR MOLECULAR IMAGING AND PHOTOTHERMAL THERAPY | UNITED STATES DEPARTMENT OF ENERGY | 2019-06-27 | — | — | US | disclosed |
| US-20160244614-A1 | SMALL MOLECULE DYE FOR MOLECULAR IMAGING AND PHOTOTHERMAL THERAPY | UNITED STATES DEPARTMENT OF ENERGY | 2016-08-25 | — | — | US | disclosed |
| US-20160244614-A1 | SMALL MOLECULE DYE FOR MOLECULAR IMAGING AND PHOTOTHERMAL THERAPY | UNITED STATES DEPARTMENT OF ENERGY | 2016-08-25 | — | — | US | disclosed |
| US-6903233-B2 | Process for producing optically active 3-halogenocarboxylic acid ester and 3-azidocarboxylic acid ester | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2005-06-07 | — | — | US | disclosed |
| US-20030225301-A1 | Process for producing optically active 3-halogenocarboxylic acid ester and 3-azidocarboxylic acid ester | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2003-12-04 | — | — | US | disclosed |
| EP-1344763-A1 | Process for producing optically active 3-halogenocarboxylic acid esters and 3-azide-carboxylic acid esters | Takasago International Corporation (JP) | 2003-09-17 | — | — | EP | disclosed |
| US-3966801-A | ANTIINFLAMMATORY AGENTS | WILLIAM H. RORER, INC. (US) | 1976-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030225301-A1 | Process for producing optically active 3-halogenocarboxylic acid ester and 3-azidocarboxylic acid ester | HDHD5, APEH, AOC3 | KMT2A 2065/4885MEN1 2962/4885PPARG 2174/4885 |
| US-10894121-B2 | Small molecule dye for molecular imaging and photothermal therapy | SLC7A5, SLC43A1, HCCS | KMT2A 3629/4885MEN1 3446/4885PPARG 2447/4885 |
| US-20190192761-A1 | SMALL MOLECULE DYE FOR MOLECULAR IMAGING AND PHOTOTHERMAL THERAPY | SLC7A5, SLC43A1, HCCS | KMT2A 3629/4885MEN1 3446/4885PPARG 2447/4885 |
| US-20160244614-A1 | SMALL MOLECULE DYE FOR MOLECULAR IMAGING AND PHOTOTHERMAL THERAPY | SLC7A5, SLC43A1, HCCS | KMT2A 3629/4885MEN1 3446/4885PPARG 2447/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.